Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF

Lai, Dulcie, Ho, King Ching, Hao, Yawei, Yang, Xiaolong · 2011 · Cancer Research

Abstract

Taxol (paclitaxel) resistance represents a major challenge in breast cancer treatment. The TAZ (transcriptional co-activator with PDZ-binding motif) oncogene is a major component of the novel Hippo–LATS signaling pathway and a transcriptional coactivator that interacts with and activates multiple transcription factors to regulate various biological processes. Here, we report that elevated levels of TAZ found in human breast cancer cells are responsible for their resistance to Taxol. DNA microarray analysis identified the oncogenes Cyr61 and CTGF as downstream transcriptional targets of TAZ. Short hairpin RNA–mediated knockdown of both Cyr61 and CTGF reversed TAZ-induced Taxol resistance in breast cancer cells. Interaction of TAZ with the TEAD family of transcription factors was essential for TAZ to activate the Cyr61/CTGF promoters and to induce Taxol resistance. Our findings define the TAZ-TEAD-Cyr61/CTGF signaling pathway as an important modifier of the Taxol response in breast cancer cells, as well as highlighting it as a novel therapeutic target to treat drug-resistant breast cancers that arise commonly at advanced stages of disease. Cancer Res; 71(7); 2728–38. ©2011 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-2711

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Cited by

See all 416

Metadata

Authors
Lai, D., Ho, K. C., Hao, Y., & Yang, X.
Affiliations
Queen's University (CA)
Venue
Cancer Research
Published
2011-03-31
Volume
71
Issue
7
Pages
2728-2738
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2129480424
Cited by
416
References
46
Citations by year
2026: 9 · 2025: 20 · 2024: 24 · 2023: 24 · 2022: 23 · 2021: 37 · 2020: 31 · 2019: 31 · 2018: 39 · 2017: 27 · 2016: 37 · 2015: 43 · 2014: 27 · 2013: 24 · 2012: 9
FWCI
10.88
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
paclitaxel resistance, breast cancer, TAZ, Hippo signaling pathway, CYR61, connective tissue growth factor, TEAD transcription factors, transcriptional coactivator, drug resistance, therapeutic target
MeSH terms
Transcriptional Coactivator with PDZ-Binding Motif Proteins, Antineoplastic Agents, Phytogenic, Breast Neoplasms, Female, Humans, Transcription Factors, Transcription, Genetic, Transfection, Trans-Activators, Gene Expression Regulation, Neoplastic, Paclitaxel, Drug Resistance, Neoplasm, Intracellular Signaling Peptides and Proteins, Connective Tissue Growth Factor, Cysteine-Rich Protein 61

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-2711
The paper
Lai, D., Ho, K. C., Hao, Y., & Yang, X. (2011). Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-2711

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.